• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜在帕金森病中起作用吗?

Does retina play a role in Parkinson's Disease?

机构信息

Department of Genetics and Molecular Biology, Vision Research Foundation, Chennai, 600 006, India.

Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, 641 043, India.

出版信息

Acta Neurol Belg. 2020 Apr;120(2):257-265. doi: 10.1007/s13760-020-01274-w. Epub 2020 Jan 21.

DOI:10.1007/s13760-020-01274-w
PMID:31965540
Abstract

Visual disorder is one of the non-motor symptoms found in Parkinson's disease (PD). It can be easily identified in the early stages even before the spread of pathological conditions to the brain parts. Studies have revealed that loss of dopamine (DA) cells in retinal layers is a prime cause for both retinal disturbance and pathological conditions of PD. This reduction of DA in retina is due to the aggregation of phosphorylated α-synuclein (aSyn) in the intra-retinal region, which eventually results in visual impairment in PD. Until now, very limited studies have been focused on the mechanism of aSyn influence and DA depletion as a cause for both retinal layer dysfunction and PD. Thus, more research is warranted to provide the missing connection between the exact role of DA and aSyn as a risk factor for visual problems in PD. Hence, the current review's focus is on the function and effects of DA degeneration in retinal cells of PD. Further, we suggest that iron plays a major role in regulating the aggregation of aSyn in the DA cells of retina and brain in PD. The study finds that the unidentified pathophysiological role of retinal degeneration in PD is an essential biomarker that needs further investigation to use it as a novel therapy in treating retinal dysfunctions in PD.

摘要

视觉障碍是帕金森病(PD)中发现的非运动症状之一。即使在病理状况扩散到大脑部位之前,它也可以在早期阶段轻松识别。研究表明,视网膜层中多巴胺(DA)细胞的丧失是视网膜紊乱和 PD 病理状况的主要原因。这种视网膜中 DA 的减少是由于磷酸化α-突触核蛋白(aSyn)在视网膜内区域的聚集,这最终导致 PD 中的视力障碍。到目前为止,很少有研究集中在 aSyn 影响和 DA 耗竭作为视网膜层功能障碍和 PD 的原因的机制上。因此,需要进行更多的研究以提供 DA 和 aSyn 作为 PD 中视觉问题风险因素的确切作用之间缺失的联系。因此,当前综述的重点是 PD 中视网膜细胞中 DA 退化的功能和影响。此外,我们认为铁在调节 PD 中视网膜和大脑 DA 细胞中 aSyn 的聚集中起主要作用。该研究发现,PD 中视网膜退化的未识别病理生理作用是一个重要的生物标志物,需要进一步研究以将其用作治疗 PD 中视网膜功能障碍的新疗法。

相似文献

1
Does retina play a role in Parkinson's Disease?视网膜在帕金森病中起作用吗?
Acta Neurol Belg. 2020 Apr;120(2):257-265. doi: 10.1007/s13760-020-01274-w. Epub 2020 Jan 21.
2
Optical coherence tomography in Parkinson's disease: is the retina a biomarker?光学相干断层扫描在帕金森病中的应用:视网膜是生物标志物吗?
J Parkinsons Dis. 2014;4(2):197-204. doi: 10.3233/JPD-130306.
3
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.小分子α-突触核蛋白错误折叠抑制剂 NPT200-11 在帕金森病动物模型中产生多种益处。
Sci Rep. 2018 Nov 1;8(1):16165. doi: 10.1038/s41598-018-34490-9.
4
Retinal Changes in Parkinson's Disease: A Non-invasive Biomarker for Early Diagnosis.帕金森病的视网膜变化:早期诊断的非侵入性生物标志物。
Cell Mol Neurobiol. 2023 Nov;43(8):3983-3996. doi: 10.1007/s10571-023-01419-4. Epub 2023 Oct 13.
5
Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.帕金森病 seeded 小鼠模型中视网膜α-突触核蛋白(pSer129)和tau 的加速积累、神经炎症和自噬失调。
Neurobiol Dis. 2019 Jan;121:1-16. doi: 10.1016/j.nbd.2018.09.013. Epub 2018 Sep 12.
6
Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process.帕金森病作为一种昼夜节律功能的神经内分泌紊乱:多巴胺 - 褪黑素失衡与退行性病变发生和进展中的视觉系统。
Rev Neurosci. 2008;19(4-5):245-316. doi: 10.1515/revneuro.2008.19.4-5.245.
7
Retinal α-synuclein deposits in Parkinson's disease patients and animal models.帕金森病患者和动物模型中的视网膜 α-突触核蛋白沉积。
Acta Neuropathol. 2019 Mar;137(3):379-395. doi: 10.1007/s00401-018-01956-z. Epub 2019 Feb 5.
8
Potential direct role of synuclein in dopamine transport and its implications for Parkinson's disease pathogenesis.α-突触核蛋白在多巴胺转运中的潜在直接作用及其对帕金森病发病机制的影响。
Biochem Biophys Res Commun. 2023 Sep 3;671:18-25. doi: 10.1016/j.bbrc.2023.05.110. Epub 2023 Jun 7.
9
Age-Related Changes of the Synucleins Profile in the Mouse Retina.年龄相关的小鼠视网膜中突触核蛋白谱的变化。
Biomolecules. 2023 Jan 15;13(1):180. doi: 10.3390/biom13010180.
10
GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease.GBA 杂合子不足通过改变帕金森病前驱模型中的脂质代谢加速α-突触核蛋白病理。
Hum Mol Genet. 2019 Jun 1;28(11):1894-1904. doi: 10.1093/hmg/ddz030.

引用本文的文献

1
Neurovascular Changes in the Retina of Parkinson's Disease Patients: A Comprehensive Study on Disease Severity, Levodopa Dosage, and Stroke Risk.帕金森病患者视网膜的神经血管变化:关于疾病严重程度、左旋多巴剂量和中风风险的综合研究
Noro Psikiyatr Ars. 2025 Aug 5;62(3):241-248. doi: 10.29399/npa.28994. eCollection 2025.
2
Retinal Neurovascular Signatures in Parkinson's Disease.帕金森病中的视网膜神经血管特征
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):10. doi: 10.1167/iovs.66.11.10.
3
Diverse Physiological Roles of Kynurenine Pathway Metabolites: Updated Implications for Health and Disease.
犬尿氨酸途径代谢物的多种生理作用:对健康与疾病的新启示
Metabolites. 2025 Mar 20;15(3):210. doi: 10.3390/metabo15030210.
4
Assessment of Changes in Vascular Density in the Layers of the Eye in Patients With Parkinson's Disease.帕金森病患者眼部各层血管密度变化的评估
Ann Neurosci. 2024 Sep 3:09727531241259841. doi: 10.1177/09727531241259841.
5
Incidence and risk factors of age-related macular degeneration in patients with Parkinson's disease: a population-based study.帕金森病患者年龄相关性黄斑变性的发病率及危险因素:一项基于人群的研究。
Front Aging Neurosci. 2024 Apr 19;16:1331786. doi: 10.3389/fnagi.2024.1331786. eCollection 2024.
6
Structural changes in the retina as a potential biomarker in Parkinson's disease: an approach from optical coherence tomography.视网膜结构变化作为帕金森病潜在生物标志物:光学相干断层扫描方法
Front Neuroimaging. 2024 Mar 1;3:1340754. doi: 10.3389/fnimg.2024.1340754. eCollection 2024.
7
Deep learning predicts prevalent and incident Parkinson's disease from UK Biobank fundus imaging.深度学习从英国生物银行眼底图像预测帕金森病的现患和发病。
Sci Rep. 2024 Feb 13;14(1):3637. doi: 10.1038/s41598-024-54251-1.
8
Ultra-Widefield Imaging of the Retinal Macrovasculature in Parkinson Disease Versus Controls With Normal Cognition Using Alpha-Shapes Analysis.使用 Alpha-Shapes 分析对认知正常的帕金森病患者与对照者的视网膜大血管进行超广角成像。
Transl Vis Sci Technol. 2024 Jan 2;13(1):15. doi: 10.1167/tvst.13.1.15.
9
Mendelian randomization reveals association between retinal thickness and non-motor symptoms of Parkinson's disease.孟德尔随机化揭示视网膜厚度与帕金森病非运动症状之间的关联。
NPJ Parkinsons Dis. 2023 Dec 13;9(1):163. doi: 10.1038/s41531-023-00611-z.
10
Retinal Changes in Parkinson's Disease: A Non-invasive Biomarker for Early Diagnosis.帕金森病的视网膜变化:早期诊断的非侵入性生物标志物。
Cell Mol Neurobiol. 2023 Nov;43(8):3983-3996. doi: 10.1007/s10571-023-01419-4. Epub 2023 Oct 13.